bromocriptine has been researched along with Drug Withdrawal Symptoms in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 32 (64.00) | 18.7374 |
1990's | 13 (26.00) | 18.2507 |
2000's | 5 (10.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiloha, RC; Mendhekar, DN | 1 |
Wu, JZ | 1 |
Borg, V; Weinholdt, T | 1 |
Bear, G; Casson, I; Durso, R; Foo, SH; Goldstein, M; Khayali, M; Kupersmith, M; Lieberman, A; Neophytides, A | 1 |
Botella-Llusia, J; De Pablos, I; Del Olmo, J; Guadalix, FJ | 1 |
Lapierre, YD; Rastogi, RB; Rastogi, SK; Singhal, RL | 1 |
Pentland, B; Sawers, JS | 1 |
Eiler, K; Lowery, R; Salstrom, D; Schaefer, MR | 1 |
Akarsu, ES; Kayaalp, SO; Uzbay, IT | 1 |
Johnson, DN; Vocci, FJ | 1 |
Kornhuber, J; Weller, M | 1 |
Bhargava, HN; Reddy, PL; Thorat, SN | 1 |
Chen, JC; Hsieh, MM; Huang, LI; Su, HJ | 1 |
Busenbark, K; Hauser, RA; Hubble, JP; Koller, WC; Malapira, T; Olanow, CW | 1 |
Bizzarri, G; Calzetti, S; Negrotti, A | 1 |
Chew, EL; Ong, KC; Ong, YY | 1 |
Foltin, RW; Gerra, G; Haney, M; Ward, AS | 1 |
Bateman, DE; Tunbridge, WM | 1 |
Davajan, V; March, CM; Mishell, DR | 1 |
Koob, GF; Markou, A | 1 |
Bauer, LO; Kranzler, HR | 1 |
Grossman, G; Martin, L; Riley, DE | 1 |
Borzecki, Z; Kaliszuk, S; Swies, Z | 1 |
Eriksson, T; Oberg, B; Pedersen, SW | 1 |
Althoff, PH; Fischer, H; Lembcke, B; Rau, H; Schmidt, K | 1 |
Clow, DW; Hammer, RP | 1 |
Extein, IL; Gold, MS; Gross, DA | 1 |
Feather, JN; Folts, DJ; Giannini, AJ; Sullivan, BS | 1 |
Kostowski, W; Krzaścik, P; Puciłowski, O; Staniszewska, A; Trzaskowska, E | 1 |
Dackis, CA; Gold, MS | 2 |
Mueller, PS | 1 |
Dackis, CA; Gold, MS; Pottash, AL | 1 |
Boyce, S; Jenner, P; Marsden, CD | 1 |
Anokhina, IP; Ivanets, NN; Nebarakova, TP; Reshchikova, EV | 1 |
Goodwin, DW; Liskow, BI | 1 |
Devenyi, P; Teller, DW | 1 |
Gawin, F; Kleber, H; Kosten, T; Morgan, C | 1 |
Baumgartel, P; DiMarzio, LR; Giannini, AJ | 1 |
Berman, ML; Tennant, F | 1 |
Baldessarini, RJ; Campbell, A; Cremens, MC; Gutierrez-Esteinou, R; Teicher, MH | 1 |
Sagherian, AA; Tennant, FS | 1 |
Kondo, H; Kuroiwa, S; Morishita, H; Nishiuchi, K; Tomioka, M | 1 |
Bonarelli, I; Manopulo, R; Marengo, M; Sturani, A | 1 |
Gold, MS; Pottash, AC; Washton, AM | 1 |
Dackis, CA; Gold, MS; Sweeney, DR | 1 |
Newman, G; Shukla, S; Turner, WJ | 1 |
Burroughs, AK; Morgan, MY; Sherlock, S | 1 |
Ciolino, C; Rosse, R | 1 |
Clark, JD; Edwards, OM; Wheatley, T | 1 |
6 review(s) available for bromocriptine and Drug Withdrawal Symptoms
Article | Year |
---|---|
Medications development at the National Institute on Drug Abuse: focus on cocaine.
Topics: Bromocriptine; Cocaine; Desipramine; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Bromocriptine in the treatment of acromegaly.
Topics: Acromegaly; Bromocriptine; Humans; Neoplasms; Pituitary Gland; Substance Withdrawal Syndrome | 1979 |
Neuroleptic malignant syndrome.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Female; Humans; Male; Neuroleptic Malignant Syndrome; Receptors, Dopamine; Substance Withdrawal Syndrome | 1985 |
Receptor changes during chronic dopaminergic stimulation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Dopamine; Humans; Hydroxydopamines; Injections, Intraperitoneal; Levodopa; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Pergolide; Primates; Pyridines; Receptors, Dopamine; Substance Withdrawal Syndrome | 1988 |
Pharmacological treatment of alcohol intoxication, withdrawal and dependence: a critical review.
Topics: Alcohol Deterrents; Alcoholic Intoxication; Alcoholism; Antidepressive Agents, Tricyclic; Bromocriptine; Cyanamide; Disulfiram; Ethanol; Fenfluramine; Humans; Lithium; Nitroimidazoles; Substance Withdrawal Syndrome; Sympathomimetics; Taurine; Tranquilizing Agents; Zimeldine | 1987 |
Pharmacological approaches to cocaine addiction.
Topics: Brain Chemistry; Bromocriptine; Cocaine; Desipramine; Dopamine; Euphoria; Humans; Receptors, Dopamine; Reward; Substance Withdrawal Syndrome; Substance-Related Disorders; Tyrosine | 1985 |
13 trial(s) available for bromocriptine and Drug Withdrawal Symptoms
Article | Year |
---|---|
Bromocriptine in the treatment of the alcohol-withdrawal syndrome.
Topics: Adult; Affective Symptoms; Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ethanol; Humans; Male; Middle Aged; Prolactin; Receptors, Dopamine; Substance Withdrawal Syndrome | 1982 |
Double-blind comparison of bromocriptine and placebo in cocaine withdrawal.
Topics: Adult; Bromocriptine; Cocaine; Double-Blind Method; Growth Hormone; Humans; Male; Middle Aged; Multivariate Analysis; Prolactin; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors; Treatment Outcome; Veterans | 1995 |
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies; Selegiline; Substance Withdrawal Syndrome | 2000 |
Long-term persistence of symptomatic effect of selegiline in Parkinson's disease. A two-months placebo-controlled withdrawal study.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Female; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Selegiline; Severity of Illness Index; Single-Blind Method; Substance Withdrawal Syndrome | 2001 |
Bromocriptine and cocaine cue reactivity in cocaine-dependent patients.
Topics: Adolescent; Adult; Bromocriptine; Cocaine; Depressive Disorder; Humans; Male; Personality Assessment; Placebo Effect; Psychiatric Status Rating Scales; Substance Abuse Detection; Substance Withdrawal Syndrome; Substance-Related Disorders; Videotape Recording | 1992 |
Bromocriptine treatment of cocaine withdrawal symptoms.
Topics: Acute Disease; Adult; Bromocriptine; Clinical Trials as Topic; Cocaine; Humans; Male; Substance Withdrawal Syndrome; Substance-Related Disorders | 1989 |
Bromocriptine and amantadine in cocaine detoxification.
Topics: Adult; Amantadine; Brain; Bromocriptine; Clinical Trials as Topic; Cocaine; Humans; Male; Random Allocation; Receptors, Dopamine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1989 |
Bromocriptine as treatment of cocaine abuse.
Topics: Adolescent; Adult; Bromocriptine; Cocaine; Female; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders | 1985 |
Bromocriptine in cocaine withdrawal--does it work?
Topics: Adolescent; Adult; Bromocriptine; Clinical Trials as Topic; Cocaine; Female; Humans; Male; Prolactin; Substance Withdrawal Syndrome; Substance-Related Disorders | 1988 |
A pilot trial of amantadine for ambulatory withdrawal for cocaine dependence.
Topics: Adult; Amantadine; Bromocriptine; Clinical Trials as Topic; Cocaine; Double-Blind Method; Humans; Patient Compliance; Substance Withdrawal Syndrome | 1988 |
Bromocriptine therapy in cocaine withdrawal.
Topics: Adult; Bromocriptine; Clinical Trials as Topic; Cocaine; Double-Blind Method; Humans; Male; Psychiatric Status Rating Scales; Random Allocation; Substance Withdrawal Syndrome | 1987 |
Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence.
Topics: Adolescent; Adult; Amantadine; Ambulatory Care; Bromocriptine; Clinical Trials as Topic; Cocaine; Double-Blind Method; Humans; Patient Compliance; Substance Withdrawal Syndrome | 1987 |
Double-blind controlled trial of bromocriptine, chlordiazepoxide and chlormethiazole for alcohol withdrawal symptoms.
Topics: Adult; Bromocriptine; Chlordiazepoxide; Chlormethiazole; Clinical Trials as Topic; Ethanol; Female; Hepatitis, Alcoholic; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Substance Withdrawal Syndrome | 1985 |
31 other study(ies) available for bromocriptine and Drug Withdrawal Symptoms
Article | Year |
---|---|
Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
Topics: Adult; Anti-Anxiety Agents; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Haloperidol; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia; Substance Withdrawal Syndrome | 2005 |
[Bromocriptine therapy of prolactinoma and hyperprolactinemia].
Topics: Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Substance Withdrawal Syndrome | 1983 |
Long-term efficacy of bromocriptine in Parkinson disease.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Middle Aged; Parkinson Disease; Substance Withdrawal Syndrome | 1980 |
The post-pill secondary amenorrhea: etiology and treatment.
Topics: Adult; Amenorrhea; Bromocriptine; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Pregnancy; Prolactin; Stimulation, Chemical; Substance Withdrawal Syndrome; Thyrotropin-Releasing Hormone | 1981 |
Bromocriptine-induced changes in dopamine and gamma aminobutyric acid in haloperidol withdrawn rats.
Topics: Animals; Bromocriptine; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Haloperidol; Humans; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substance Withdrawal Syndrome | 1982 |
Galactorrhoea after withdrawal of bromocriptine.
Topics: Adult; Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Parkinson Disease; Pregnancy; Prolactin; Substance Withdrawal Syndrome | 1980 |
Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats.
Topics: Acoustic Stimulation; Alcohol Drinking; Animals; Behavior, Animal; Bromocriptine; Dopamine; Ethanol; Haloperidol; Male; Motor Activity; Rats; Rats, Wistar; Seizures; Substance Withdrawal Syndrome | 1994 |
Amantadine withdrawal and neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1993 |
Evidence for the behavioral supersensitivity of dopamine D2 receptors without receptor up-regulation in morphine-abstinent rats.
Topics: Animals; Behavior, Animal; Body Temperature; Brain Chemistry; Bromocriptine; Drug Tolerance; Kinetics; Male; Morphine Dependence; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Spinal Cord; Spiperone; Substance Withdrawal Syndrome; Up-Regulation | 1993 |
Reductions in binding and functions of D2 dopamine receptors in the rat ventral striatum during amphetamine sensitization.
Topics: Adenylyl Cyclases; Amphetamine; Analysis of Variance; Animals; Bromocriptine; Colforsin; Corpus Striatum; Cyclic AMP; Drug Administration Schedule; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Injections, Intraperitoneal; Male; Motor Activity; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior; Substance Withdrawal Syndrome; Time Factors | 1999 |
Neuroleptic malignant syndrome without neuroleptics.
Topics: Antiparkinson Agents; Bromocriptine; Creatine Kinase; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 2001 |
Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans.
Topics: Adult; Analysis of Variance; Bromocriptine; Crack Cocaine; Fenfluramine; Humans; Hydrocortisone; Male; Middle Aged; Motivation; Prolactin; Self Administration; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 2001 |
Ovulation induction in amenorrheic women.
Topics: Amenorrhea; Bromocriptine; Clomiphene; Female; Galactorrhea; Humans; Menotropins; Ovulation Induction; Pregnancy; Progesterone; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1979 |
Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal.
Topics: Analysis of Variance; Animals; Bromocriptine; Cocaine; Disease Models, Animal; Male; Rats; Rats, Wistar; Regression Analysis; Self Stimulation; Substance Withdrawal Syndrome | 1992 |
Acute respiratory failure from dopamine agonist withdrawal.
Topics: Acute Disease; Bromocriptine; Female; Humans; Middle Aged; Parkinson Disease; Respiratory Insufficiency; Substance Withdrawal Syndrome | 1992 |
The influence of agonists and antagonists of dopaminergic system on the formation of audiogenic seizures in rats during the ethanol abstinence period.
Topics: Amantadine; Animals; Bromocriptine; Dopamine Agents; Dopamine Antagonists; Ethanol; Haloperidol; Male; Metoclopramide; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Sulpiride | 1990 |
Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Female; Gait; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Substance Withdrawal Syndrome | 1991 |
Effect of bromocriptine withdrawal in acromegaly on body composition as assessed by bioelectrical impedance analysis.
Topics: Acromegaly; Adolescent; Blood Glucose; Body Composition; Body Mass Index; Body Water; Body Weight; Bromocriptine; Child, Preschool; Electrophysiology; Female; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Plethysmography, Impedance; Substance Withdrawal Syndrome | 1991 |
Cocaine abstinence following chronic treatment alters cerebral metabolism in dopaminergic reward regions. Bromocriptine enhances recovery.
Topics: Analysis of Variance; Animals; Autoradiography; Brain; Bromocriptine; Carbon Radioisotopes; Cocaine; Deoxyglucose; Dopamine; Glucose; Male; Organ Specificity; Rats; Rats, Inbred Strains; Reference Values; Reward; Substance Withdrawal Syndrome | 1991 |
On the relative importance of D-1 vs. D-2 dopaminergic receptors in the control of audiogenic seizures in ethanol withdrawn rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acoustic Stimulation; Animals; Benzazepines; Bromocriptine; Ethanol; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Seizures; Substance Withdrawal Syndrome | 1989 |
Central stimulant abuse: neurochemistry and pharmacotherapy.
Topics: Antipsychotic Agents; Brain; Bromocriptine; Cocaine; Desipramine; Dopamine; Euphoria; Humans; Receptors, Dopamine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1986 |
[Dopamine receptor stimulants in the treatment of alcoholism].
Topics: Alcoholism; Apomorphine; Bromocriptine; Dopamine; Dopamine Agents; Drug Evaluation; Ethanol; Humans; Male; Substance Withdrawal Syndrome | 1988 |
Stepwise detoxification from cocaine. A promising regimen.
Topics: Adolescent; Adult; Amantadine; Bromocriptine; Cocaine; Desipramine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan; Tyrosine | 1988 |
Interactions of bromocriptine with cocaine.
Topics: Adult; Bromocriptine; Cocaine; Drug Interactions; Female; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders | 1988 |
Pulsatile luteinizing hormone secretion and clomiphene and bromocriptine response in amenorrheic women with normoprolactinemia and gestagen withdrawal bleeding.
Topics: Adult; Amenorrhea; Bromocriptine; Clomiphene; Female; Humans; Luteinizing Hormone; Ovulation; Progestins; Prolactin; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1987 |
[Treatment of alcohol withdrawal syndrome. The experience with bromocriptine].
Topics: Adult; Aged; Alcoholism; Bromocriptine; Drug Evaluation; Female; Humans; Male; Middle Aged; Substance Withdrawal Syndrome | 1986 |
'Crack'. Early report on a new drug epidemic.
Topics: Adult; Black or African American; Bromocriptine; Cocaine; Humans; Male; Random Allocation; Sampling Studies; Substance Withdrawal Syndrome; Substance-Related Disorders | 1986 |
The physiology of cocaine craving and 'crashing'.
Topics: Bromocriptine; Cocaine; Dopamine; Humans; Prolactin; Substance Withdrawal Syndrome; Substance-Related Disorders | 1987 |
Bromocriptine-related psychosis and treatment.
Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Pituitary Neoplasms; Prolactin; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Valproic Acid | 1985 |
Dopamine agonists and neuroleptic malignant syndrome.
Topics: Alzheimer Disease; Amantadine; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome | 1985 |
Rapid enlargement of non-functioning pituitary tumour following withdrawal of bromocriptine.
Topics: Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin; Substance Withdrawal Syndrome | 1985 |